person
as of 2026-07-01Matcheri S. Keshavan, MD
Matcheri KeshavanMatcheri Keshavan, MDMatcheri S Keshavan, MD
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 9
2 publications · 1 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Beth Israel Deaconess Medical Center/ Massachusetts Mental Health Center
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
9
Publications
2 (1 high-value)
Trial investigator
yes
Trials led
6
Cognitive Enhancement Therapy for Early-Stage Schizophrenia
NCT00167362Phase 3Completed
Adaptation of Cognitive Enhancement Therapy for Persons at Clinical High Risk for Psychosis
NCT02459210—Completed
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
NCT06740383—Recruiting
Comparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness)
NCT04321759—Unknown
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
NCT01561859—Completed
Systematic Evaluation of Antiviral Medication in Schizophrenia
NCT00514449Phase 2Completed
Publications & congress
2
Guidelines for the prevention of psychosis from the World Federation of Societies of Biological Psychiatry (WFSBP) and EPI Canada.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2026 · high-value
Reframing schizophrenia as a neurodevelopmental syndrome: The scientific and social imperative.
Schizophrenia research · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR